All News #Library
Rare Diseases
Tempus, Verastem Team on CDx for KRAS-Mutant Ovarian Cancer
20 May 2025 //
BUSINESSWIRE
FDA grants Verastem 1st approval for rare ovarian cancer treatment
09 May 2025 //
ENDPTS
Verastem Receives Orphan Drug Designation from FDA for Avutometinib Alone
05 Mar 2024 //
BUSINESSWIRE

Market Place
Sourcing Support